Zm. Du et al., EFFICIENT EX-VIVO INHIBITION OF PERFORIN AND FAS LIGAND EXPRESSION BYCHIMERIC TRANSFER-RNA-HAMMERHEAD RIBOZYMES, Human gene therapy, 9(11), 1998, pp. 1551-1560
Citations number
31
Categorie Soggetti
Genetics & Heredity","Biothechnology & Applied Migrobiology","Medicine, Research & Experimental
Graft-versus-host disease (GVHD) is a feared complication of allogenei
c bone marrow transplantation. Research in rodent models has linked pe
rforin and Fas ligand (FasL), two components of independent lytic path
ways, with the induction of GVHD, In this study we characterized two h
ammerhead ribozymes that cleave their target perforin and Fas ligand R
NAs with high efficiency in CTLL-2 cells. The perforin and Fas ligand
ribozymes were expressed from a tRNA-directed RNA polymerase III promo
ter that was inserted in an episomal multicopy plasmid derived from pa
pilloma virus. Chimeric anti-perforin and anti-Fast tRNA-ribozymes had
sequences engineered in order to have specific secondary structure ef
fects. These sequence modifications allow the formation of a 5' --> 3'
stem structure and also place the ribozyme in a flexible bulge region
that keeps the ribozyme separated from the tRNA domain. Northern and
RT in situ PCR analyses showed high levels of transcription and effici
ent transportation to the cytoplasm, The expression of perforin and Ea
st in CTLL-2 cells was significantly reduced as assessed by RNA and pr
otein analyses.